Seratrodast: A Potent TP Receptor Antagonist for Asthma Management
Discover the therapeutic advantages of Seratrodast, a key player in managing asthma and other respiratory conditions. Explore its mechanism of action, clinical efficacy, and why sourcing from a trusted manufacturer in China is crucial for quality and consistency.
Get a Quote & SampleUnlocking Respiratory Relief with a Leading TP Receptor Antagonist
Seratrodast
As a leading supplier of high-quality pharmaceutical intermediates, we offer Seratrodast, a potent and selective thromboxane A2 (TXA2) receptor antagonist. This compound plays a critical role in treating asthma by blocking the effects of TXA2, a substance that causes bronchoconstriction and airway inflammation. Trust NINGBO INNO PHARMCHEM CO.,LTD. as your reliable manufacturer and supplier in China for this essential API.
- Explore Seratrodast for Asthma Treatment: Learn how this TP receptor antagonist can be a cornerstone in your respiratory health formulations.
- Source High Purity Pharmaceutical Intermediates: We guarantee 99% purity for Seratrodast, ensuring optimal performance and safety in your products.
- Reliable Manufacturer & Supplier in China: Benefit from consistent supply, competitive pricing, and stringent quality control from NINGBO INNO PHARMCHEM CO.,LTD.
- Investigate Clinical Applications: Understand the proven efficacy of Seratrodast in treating asthma, allergic rhinitis, and chronic bronchitis.
Key Advantages of Seratrodast for Your Formulations
Selective TP Receptor Antagonism
Seratrodast acts as a highly selective antagonist of the thromboxane A2 receptor (TP receptor), effectively mitigating TXA2-mediated effects like airway smooth muscle contraction and plasma extravasation, crucial for managing asthma symptoms.
Proven Efficacy in Respiratory Conditions
Clinical studies demonstrate Seratrodast's significant improvements in lung function parameters (FEV1, FVC, PEF) and reduction in asthma symptoms such as wheezing and shortness of breath, making it a valuable API to buy.
Comprehensive Safety Profile
With extensive clinical experience, Seratrodast has shown a favorable safety profile, with adverse reactions being generally mild to moderate and transient. This makes it a dependable choice for pharmaceutical manufacturers seeking quality ingredients.
Diverse Applications of Seratrodast
Asthma Management
Seratrodast is a primary pharmaceutical intermediate for anti-asthmatic drugs, offering direct benefits in controlling airway inflammation and hyper-responsiveness. Secure your supply for effective asthma therapies.
Allergic Rhinitis Relief
Its efficacy extends to treating allergic rhinitis, providing significant relief from nasal obstruction, discharge, and sneezing, making it a versatile compound for pharmaceutical formulation.
Chronic Bronchitis Support
Research indicates Seratrodast can improve cough thresholds in patients with chronic bronchitis, highlighting its potential in managing chronic respiratory ailments.
COPD Treatment Considerations
Studies suggest Seratrodast may offer benefits in improving respiratory distress and lung function in patients with chronic pulmonary emphysema (a form of COPD), making it an area for further investigation.